极速赛车

Fed. Circ. Agrees MS Generic Drug Didn't Infringe Metacel IP

By Adam Lidgett ( April 23, 2025, 9:07 PM EDT) -- The Federal Circuit on Wednesday backed a New Jersey federal judge's finding that Rubicon Research's generic version of Metacel's drug Ozobax does not induce doctors and patients to infringe a Metacel patent....

极速赛车 is on it, so you are, too.

A 极速赛车 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A 极速赛车 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience 极速赛车 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login